Analysis of a new highly active corticosteroid.
D001623:Betamethasone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*
D001623:Betamethasone